What Pharmazz does
Founded in 2010, Pharmazz operates in Health Tech offering novel products in critical care medicine. The company has developed Centhaquine for hypovolemic shock and Sovateltide for cerebral ischemic stroke, both of which have received FDA approval for phase III INDs. In India, Pharmazz has secured marketing authorization for these first-in-class drug molecules and has partnered with Sun Pharmaceutical and Dr. Reddy s Laboratories to market them. The company s goal is to improve treatment options for patients experiencing critical health conditions. Additional information can be found on the companys website.
Who runs it
Funding and finances
Why this matters to you: funding stage is a rough proxy for how long the runway is and how much structure to expect. It is not a promise, and a profitable bootstrapped company can be the safer bet.
Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.
Questions and experiences
Nobody has asked anything about Pharmazz yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.
Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.